Biolegend, 109806, FITC anti-mouse CD45.2 Antibody, 500μg

CD45.2 is an alloantigen of CD45, expressed by Ly5.2 bearing mouse strains (e.g., A, AKR, BALB/c, CBA/Ca, CBA/J, C3H/He, C57BL, C57BR, C57L, C58, DBA/1, DBA/2, NZB, SWR, 129). CD45, a member of the protein tyrosine phosphatase (PTP) family, is a 180-240 kD glycoprotein expressed on all hematopoietic cells except mature erythrocytes and platelets. There are multiple isoforms in the mouse that play key roles in TCR and BCR signal transduction. These isoforms are very specific to the activation and maturation states of the cell as well as specific cell type. The primary ligands for CD45 are galectin-1, CD2, CD3, CD4, TCR, CD22, and Thy-1.
500μg
Verified Reactivity: Mouse
Antibody Type: Monoclonal
Host Species: Mouse
Immunogen: B10.S mouse thymocytes and splenocytes
Formulation: Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.
Preparation: The antibody was purified by affinity chromatography, and conjugated with FITC under optimal conditions.
Concentration: 0.5 mg/ml
Storage & Handling: The antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.
Application: FC - Quality tested
Recommended Usage: Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is ≤ 0.25 µg per 106 cells in 100 µl volume. It is recommended that the reagent be titrated for optimal performance for each application.
Excitation Laser: Blue Laser (488 nm)
Application Notes: The 104 antibody does not react with mouse cells expressing the CD45.1 alloantigen. Additional reported applications (for the relevant formats) include: immunoprecipitation4, in vivo and in vitro blocking of B cell responses1,2, and immunohistochemical staining of acetone-fixed frozen sections3.
Application References(PubMed link indicates BioLegend citation): Yakura H, et al. 1983. J. Exp. Med. 157:1077. (Block) Yakura H, et al. 1986. J. Immunol. 136:2729. (Block) Suzuki K, et al. 2000. Immunity 13:691. (IHC) Shen FW, et al. 1986. Immunogenetics 24:146. (IP) Baldwin TA and Hogquist KA. 2007. J. Immunol. 179:837. Pascal V, et al. 2007. J. Immunol. 179:1751. Burman AC, et al. 2007. Blood 110:1064. Kincaid EZ, et al. 2007. J. Immunol. 179:3187. Phan TG, et al. 2007. Nature Immunol. 8:992. Nakano-Yokomizo T, et al. 2011. J. Exp Med. 208:1661. PubMed Wen T, et al. 2013. PNAS. 110:6067. PubMed Kohlmeier JE, et al. 2008. Immunity. 29:101. (FC) PubMed
Product Citations: Koyama M, et al. 2015. J Exp Med. 212: 1303 - 1321. PubMed Rundberg Nilsson A, et al. 2023. iScience. 26:106341. PubMed Coelho DR, et al. 2023. iScience. 26:106442. PubMed Zheng J, et al. 2022. Front Pharmacol. 13:866228. PubMed Miranda K, et al. 2022. iScience. 25:104994. PubMed Behr FM, et al. 2021. Eur J Immunol. 51:151. PubMed Tian WJ, et al. 2021. Clin Exp Pharmacol Physiol. 48:902. PubMed He D, et al. 2022. Immunity. 55:159. PubMed Zhang D, et al. 2022. Cell Stem Cell. 29:232. PubMed Wang D, et al. 2022. Cell Rep. 39:110587. PubMed Jiang W, et al. 2022. Redox Biol. 56:102432. PubMed Koutník J, et al. 2022. Front Immunol. 13:1049033. PubMed Scherer S, et al. 2023. Nat Immunol. 24:501. PubMed De Giovanni M, et al. 2022. Cell. 185:815. PubMed Michalova J, et al. 2011. Biol Blood Marrow Transplant. 17:1273. PubMed Otano I, et al. 2021. Nat Commun. 12:7296. PubMed MacDonald K, et al. 2014. J Immunol. 192:3180. PubMed Tan X, et al. 2016. PLoS One. 11: 0160985. PubMed Stewart I et al. 2018. Immunity. 49(3):477-489 . PubMed Kim CJ, et al. 2018. Immunity. 49:1034. PubMed Piepke M, et al. 2021. J Neuroinflammation. 18:265. PubMed Acharya N, et al. 2020. Immunity. 53(3):658-671.e6. PubMed Burman A, et al. 2007. Blood. 110:1064. PubMed Bhattacharjee S, et al. 2019. Cell Rep. 28:231. PubMed Sultan H, et al. 2018. Cancer Immunol Res. 6:617. PubMed Yuzhu Hou et al. 2018. Immunity. 49(3):490-503 . PubMed Yang X, et al. 2020. Blood Sci. 2:89. PubMed Liang Y, et al. 2020. J Immunol. 204:2984. PubMed Wei Q, et al. 2021. Nat Commun. 12:2522. PubMed Atkin-Smith G, et al. 2017. Sci Rep. 7:39846. PubMed Okuniewska M, et al. 2021. Cell Reports. 36(2):109368. PubMed Brooks JF, et al. 2020. Cytotherapy. 22:436. PubMed Swidergall M, et al. 2019. Cell Rep. 28:423. PubMed Liu Y, et al. 2021. Haematologica. Online ahead of print. PubMed Mitchell JE, et al. 2021. Cell Reports. 35(2):108966. PubMed Tran L, et al. 2017. Cancer Immunol Res. 5:1141. PubMed Khan IM, et al. 2021. Immunohorizons. 5:703. PubMed Emgård J, et al. 2018. Immunity. 143:419. PubMed Uchil PD et al. 2018. Cell host & microbe. 25(1):87-100 . PubMed Wang H, et al. 2019. Nat Commun. 10:1898. PubMed Schulz A, et al. 2019. Cell Rep. 29:1074. PubMed Guiducci E, et al. 2018. Front Immunol. 1.467361111. PubMed Zhang J, et al. 2022. iScience. 25:104963. PubMed Kaplan BLF et al. 2018. Current protocols in toxicology. 75:11:00 25. PubMed Kleppe M et al. 2018. Cancer cell. 33(1):29-43 . PubMed Trompette A, et al. 2022. Mucosal Immunol. :. PubMed Zhang B, et al. 2021. Nat Biomed Eng. 5:1288. PubMed Li J, et al. 2020. Elife. 9:00. PubMed Li Y, et al. 2020. Cell Stem Cell. 27(5):732-747.e7. PubMed Derecka M, et al. 2020. Nat Immunol. 261:21. PubMed Friedman DJ, et al. 2021. Cancer Immunol Res. 9:952. PubMed Glaros V, et al. 2021. Immunity. 54:2005. PubMed Wan X, et al. 2018. Nature. 560:107. PubMed Malik A et al. 2018. Immunity. 49(3):515-530 . PubMed Bergin SM, et al. 2021. Brain Behav Immun. 95:477. PubMed Chen X, et al. 2021. Cell Rep. 37:109991. PubMed Faulhaber LD, et al. 2022. Neurophotonics. 9:031917. PubMed Kruta M, et al. 2021. Cell Stem Cell. :. PubMed Platteel A, et al. 2017. Vaccine.. 10.1016/j.vaccine.2017.10.044. PubMed Abbott RK, et al. 2018. Immunity. 48:133. PubMed Bijalwan M, et al. 2019. Sci Rep. 9:3444. PubMed Dey S, et al. 2020. J Immunother Cancer. 8:. PubMed Huang D, et al. 2020. Nat Commun. 4.520833333. PubMed Leon-Rico D, et al. 2015. Lab Anim. 49:132. PubMed Stifter SA, et al. 2019. Cell Rep. 29:3539. PubMed Landon J Edgar et al. 2018. Cell chemical biology. 26(1):131-136 . PubMed Ma W, et al. 2017. Cell Death & Disease. 10.1038/cddis.2017.47. PubMed Uslu M, et al. 2020. J Cell Physiol. 235:9644. PubMed Bates PD, et al. 2021. Front Immunol. 12:668307. PubMed Burgess M, et al. 2014. Blood. 124:3947. PubMed Kesavardhana S, et al. 2020. J Biol Chem. 295:8325. PubMed Xu P, et al. 2020. Cancer Immunol Res. 8:1193. PubMed Morelli AE, et al. 2020. Cell Rep. 30:3448. PubMed Zhang W, et al. 2022. Nat Methods. 19:759. PubMed Chen R, et al. 2021. Cell Reports. 34(7):108751. PubMed Wu B, et al. 2021. Immunity. 54(2):308-323.e6. PubMed Swanson P, et al. 2016. PLoS Pathog. 12:e1006022. PubMed de Laval B, et al. 2020. Cell Stem Cell. 26(5):657-674. PubMed Williams JB, et al. 2020. Nat Commun. 0.876388889. PubMed Nelson CE et al. 2019. Cell Rep. 28(12):3092-3104 . PubMed Zeis P, et al. 2020. Immunity. 53:775. PubMed Jaako P, et al. 2016. Leukemia. 10.1038/leu.2016.159. PubMed Kang YH, et al. 2019. Nat Commun. 10:912. PubMed Alexander Mildner et al. 2017. Immunity. 46(5):849-862 . PubMed Li E, et al. 2021. Front Immunol. 12:667177. PubMed Kissiov DU, et al. 2022. Elife. 11:. PubMed Zhang C, et al. 2021. J Immunother Cancer. 9:. PubMed Peter Morawski, Chen-Feng Qi, Silvia Boll 2017. Sci Rep. 7:40838. PubMed Zhu YP et al. 2018. Cell reports. 24(9):2329-2341 . PubMed Düking T, et al. 2022. Sci Adv. 8:eabo7639. PubMed Ma L, et al. 2022. Sci Adv. 8:eabm3470. PubMed Koide S, et al. 2022. iScience. 25:103603. PubMed Okuyama Y, et al. 2020. FASEB J. 540:34. PubMed Sade–Feldman M, et al. 2018. Cell. 175:998. PubMed Field CS, et al. 2020. Cell Metab. 31:422. PubMed Magee JA, et al. 2021. Stem Cell Reports. 16:20. PubMed Kohn M, et al. 2021. Front Immunol. 626627:12. PubMed Ubags ND, et al. 2021. J Allergy Clin Immunol. 1049:147. PubMed Bosma M, et al. 2016. Nat Commun. 7: 11314. PubMed Andresen L, et al. 2016. PLoS One. 11: 0148428. PubMed Zhang J, et al. 2019. Exp Hematol. 78:21:00. PubMed Hidalgo San Jose L, et al. 2020. Cell Rep. 30:69. PubMed Gundra UM, et al. 2017. Nat Immunol. 1.195833333. PubMed Halvarsson C, et al. 2019. Antioxid Redox Signal. 31:211. PubMed Heckler M, et al. 2021. Cancer Discov. Online ahead of prin. PubMed Stienstra R, et al. 2014. Diabetes. 63:4143. PubMed Corrado M, et al. 2020. Cell Metab. 32:981. PubMed Goldberg EL, et al. 2021. Cell Metabolism. :. PubMed Radulovic V, et al. 2020. Cell Reports. 27(10):2826-2836.e5.. PubMed Hung LY, et al. 2019. J Immunol. 203:511. PubMed Koyama M et al. 2019. Immunity. 51(5):885-898 . PubMed Bing Wu et al. 2018. Immunity. 49(5):886-898 . PubMed Hsieh WC, et al. 2018. Nat Commun. 9:463. PubMed Sethuraman SN, et al. 2020. Theranostics. 10:3397. PubMed
RRID: AB_313442 (BioLegend Cat. No. 109805) AB_313443 (BioLegend Cat. No. 109806)
Structure: Protein tyrosine phosphatase (PTP) family, 180-240 kD
Distribution: All hematopoietic cells except mature erythrocytes and platelets of the CD45.2 strain of mice
Function: Phosphatase, T and B cell activation
Ligand/Receptor: Galectin-1, CD2, CD3, CD4
Biology Area: Cell Biology, Immunology, Inhibitory Molecules, Innate Immunity, Neuroscience, Neuroscience Cell Markers
Molecular Family: CD Molecules
Antigen References: 1. Suzuki K, et al. 2000. Immunity 13:691.
Gene ID: 19264
UniProt: View information about CD45.2 on UniProt.org
Clone: 104
Regulatory Status: RUO
Other Names: Ly-5.2, LCA
Isotype: Mouse (SJL) IgG2a, κ